41
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:July 27, 2020Active, not recruiting
Metastatic Prostate Carcinoma in the Soft Tissue: 113 Clinical Trials, Page 5 of 12
Hide Studies Not Open or Pending
42
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition(s):Metastatic Hormone Sensitive Prostate CancerLast Updated:July 7, 2020Active, not recruiting
43
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Condition(s):Metastatic Castrate Resistant Prostate CancerLast Updated:November 22, 2019Terminated
44
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Condition(s):Metastatic Castration-Resistant Prostate CancerLast Updated:November 15, 2018Completed
45
ProBio: A Biomarker Driven Study in Patients With Metastatic Castrate Resistant Prostate Cancer
Condition(s):Metastatic Castration-Resistant Prostatic CancerLast Updated:December 2, 2019Recruiting
46
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Condition(s):Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Metastatic Prostate Small Cell Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:July 15, 2020Not yet recruiting
47
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Soft Tissue Metastases; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate CancerLast Updated:December 3, 2018Completed
48
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:August 12, 2020Active, not recruiting
49
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Condition(s):Prostatic NeoplasmsLast Updated:July 20, 2020Active, not recruiting
50
18F-DCFBC PET/CT in Prostate Cancer
Condition(s):Prostatic Neoplasms; Prostate CancerLast Updated:April 23, 2019Completed